{"nct_id":"NCT05266105","title":"A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-06","start_date":"2021-12-10","start_date_type":"ACTUAL","primary_completion_date":"2025-01","primary_completion_date_type":"ESTIMATED","completion_date":"2025-07","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["OLMA"]}